<span id="midArticle_start"/>May 4 (Reuters) - Sygnis AG :
<span id="midArticle_0"/>* Signs non-exclusive distribution agreement with CambridgeBioscience Ltd. for UK and Ireland
<span id="midArticle_1"/>* Under terms of agreement, Cambridge Bioscience willpromote, market, sell and support TruePrime products forprimer-free WGA as well as SunScript thermostable reversetranscriptase kitsSource text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_2"/>
<span id="midArticle_0"/>* Signs non-exclusive distribution agreement with CambridgeBioscience Ltd. for UK and Ireland
<span id="midArticle_1"/>* Under terms of agreement, Cambridge Bioscience willpromote, market, sell and support TruePrime products forprimer-free WGA as well as SunScript thermostable reversetranscriptase kitsSource text for Eikon: Further company coverage: (Gdynia Newsroom)
<span id="midArticle_2"/>
via Smart Health Shop Forum http://ift.tt/1dHffZQ
No comments:
Post a Comment